Last reviewed · How we verify
NCT06139120
The Segmental Distribution of Hypersensitivity in Patients With Chronic Subacromial Pain Syndrome
trial testing Assessment of hypersensitivity in Subacromial Pain Syndrome in 116 participants. Completed in 30 December 2022.
20 December 2022
Quick facts
| Lead sponsor | Cukurova University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 116 |
| Start date | 20 September 2022 |
| Primary completion | 20 December 2022 |
| Estimated completion | 30 December 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Assessment of hypersensitivity
Conditions studied
- Subacromial Pain Syndrome — all drugs for Subacromial Pain Syndrome →
- Central Sensitisation — all drugs for Central Sensitisation →
Sponsor
Cukurova University
Who can join
Adults 18 to 65, any sex, with Subacromial Pain Syndrome or Central Sensitisation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aimed to determine the distribution of pain sensitivity according to body segments in patients with central sensitization associated with chronic subacromial pain syndrome (SPS).This cross-sectional study included patients with chronic SPS and central sensitization (patient group) and the same number of healthy participants as controls. The presence of central sensitization was determined using the Central Sensitization Inventory. To determine the segmental distribution of pain sensitivity, pressure pain threshold measurements were performed bilaterally from the shoulder, forearm, and leg.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06139120
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Subacromial Pain Syndrome
Currently open trials in the same condition.
- NCT07415967 — The Effect of a Dual-Task Technique-Based Exercise Program on Clinical Outcomes in Rotator Cuff Related Shoulder Pain · NA · recruiting
- NCT07324343 — Which Patient Group Shows Greater Improvement With Patient Education Alone in Rotator Cuff-Related Shoulder Pain? - A Co · NA · recruiting
- NCT06409442 — Effects of Corrective External Support and Regional Vibration Applications in Subacromial Pain Syndrome · NA · recruiting
- NCT06449534 — The Effect of the Treatment Environment on Pain, Function, Self Efficacy and Satisfaction in RCRSP · NA · recruiting
- NCT04923477 — Therapeutic Exercise for Rotator Cuff Tendinopathy / Subacromial Pain Syndrome - Outcomes and Mechanisms · NA · recruiting
Other Cukurova University trials
Trials by the same sponsor.
- NCT07464652 — Objectıve Structured Clınıcal Examınatıon Stress For Intravenous Perıpheral Catheterızatıon · NA · not yet recruiting
- NCT07458789 — Breastfeeding Education · NA · not yet recruiting
- NCT07346482 — Determining the Effect of Midwife-Led Safe Infant Care Training for Pregnant Women on Awareness of Sudden Infant Death S · NA · not yet recruiting
- NCT07248904 — The Effect of a Transtheoretical Model-Based Educational Intervention on First-Year Nursing Students' HPV Knowledge, Hea · NA · recruiting
- NCT07241949 — Regional Analgesia Techniques for Laparoscopic Cholecystectomy · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06139120 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cukurova University
- Last refreshed: 18 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06139120.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing